Patient
SITE005-0045
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2025-10-25
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-07-09 (study day 69); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-06 (study day 66); relationship: NOT RELATED
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-06-30 (study day 60); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-06-22 (study day 52); relationship: RELATED
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-06-21 (study day 51); relationship: not assessed
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-06-03 (study day 33); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.